Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalassemia major patients. The main modality for detecting cardiac iron toxicity is MRI T2* with limited availability. This study aims to obtain iron toxicity profiles in transfusion-dependent beta-thalassemia patients; to see a correlation between iron toxicity and cardiac function. Methods: We conducted a cross-sectional study at the Adult Thalassemia Polyclinic of Cipto Mangunkusumo Hospital, Indonesia from December 2017 to March 2018. We performed the statistical analysis using Pearson/Spearman Test comparing MRI T2* values with ejection fraction and E/A ratio. Results: The median of 4-months mean of ferritin levels was 5130 ng/mL. The mean fo...
<p><strong>BACKGROUND:</strong> The assessment of cardiac iron overload in thalassemia major has bee...
Iron overload cardiomyopathy remains the major cause of death in patients with transfusion-dependent...
Abstract Background and Objective: Many thalassemia patients don't have any symptoms until the dise...
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalas...
Background: Paediatric patients with transfusion dependent thalassemia require regular lifelong red ...
Background: Frequent blood transfusions lead to various complications in patients with thalassemia m...
Introduction: Thalassemia is the most common genetic disorder worldwide. Regular transfusion therapy...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Background The aims of our study were to evaluate (i) the relationship between cardiac T2* values an...
Objective: Cardiac T2* magnetic resonance imaging (MRI) has recently attracted considerable attentio...
Background and purpose: Cardiac magnetic resonance imaging (MRI) is a costly method to assess cardia...
Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is as...
Introduction: In this study, we aimed to assess the relationship of cardiac and hepatic T2* magnetic...
PubMed ID: 21647857PURPOSE: Cardiac involvement in thalassemia major (TM) is mainly characterized by...
Objectives: Organ-specific hemosiderosis and iron overload complications are more serious and more f...
<p><strong>BACKGROUND:</strong> The assessment of cardiac iron overload in thalassemia major has bee...
Iron overload cardiomyopathy remains the major cause of death in patients with transfusion-dependent...
Abstract Background and Objective: Many thalassemia patients don't have any symptoms until the dise...
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalas...
Background: Paediatric patients with transfusion dependent thalassemia require regular lifelong red ...
Background: Frequent blood transfusions lead to various complications in patients with thalassemia m...
Introduction: Thalassemia is the most common genetic disorder worldwide. Regular transfusion therapy...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Background The aims of our study were to evaluate (i) the relationship between cardiac T2* values an...
Objective: Cardiac T2* magnetic resonance imaging (MRI) has recently attracted considerable attentio...
Background and purpose: Cardiac magnetic resonance imaging (MRI) is a costly method to assess cardia...
Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is as...
Introduction: In this study, we aimed to assess the relationship of cardiac and hepatic T2* magnetic...
PubMed ID: 21647857PURPOSE: Cardiac involvement in thalassemia major (TM) is mainly characterized by...
Objectives: Organ-specific hemosiderosis and iron overload complications are more serious and more f...
<p><strong>BACKGROUND:</strong> The assessment of cardiac iron overload in thalassemia major has bee...
Iron overload cardiomyopathy remains the major cause of death in patients with transfusion-dependent...
Abstract Background and Objective: Many thalassemia patients don't have any symptoms until the dise...